Ignite Creation Date:
2025-12-24 @ 4:58 PM
Ignite Modification Date:
2026-04-11 @ 7:06 AM
Study NCT ID:
NCT06667050
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-10-31
First Post:
2024-10-27
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
CAPOX Plus Sintilimab and Bevacizumab Biosimilar (IBI305) for Neoadjuvant Treatment of Locally Advanced Gastric Cancer
Sponsor:
Organization: